Filtyp
Dosimetry Relativdosimetri Crister Ceberg Medical Radiation Physics Lund University Sweden Reference geometry Treatment unit Ion chamber => monitor units, UR Measurement point => absorbed dose, DR Water tank 𝐷𝑅 = 𝐷𝑅 𝑈𝑅 Treatment geometry • Distance from source, f • Collimator setting, c • Treatment depth in patient, z Relative dosimetry Reference geometry Treatment geometry fR f DDR z zR ccR
https://www.msf.lu.se/sites/msf.lu.se/files/4._relativdosimetri.pdf - 2026-04-30
Verksamhetsplan 2018 för EBSCO Systems Nordic User Group Antagen av styrelsen: 2018-05-09 Styrelsen ska under verksamhetsåret fortsätta arbetet med att komma med förslag på förbättringar i de EBSCO system som gruppens medlemmar använder och att utveckla kontakten och samarbetet mellan bibliotek och organisationer kring desamma. För att vara en relevant användargrupp är styrelsen beroende av att me
https://www.ub.lu.se/sites/ub.lu.se/files/verksamhetsplan_2018_for_eds_nordic_user_group.pdf - 2026-04-30
Verksamhetsplan 2019 för EBSCO Systems Nordic User Group Antagen av styrelsen: 2019-05-09 Styrelsen ska under verksamhetsåret fortsätta arbetet med att komma med förslag på förbättringar i de EBSCO-system som gruppens medlemmar använder och att utveckla kontakten och samarbetet mellan bibliotek och organisationer kring desamma. För att vara en relevant användargrupp är styrelsen beroende av att me
https://www.ub.lu.se/sites/ub.lu.se/files/verksamhetsplan_2019_for_ebsco_systems_nordic_user_group.pdf - 2026-04-30
Verksamhetsplan 2020 för EBSCO Systems Nordic User Group Antagen av styrelsen: 2020-05-14 Styrelsen ska under verksamhetsåret fortsätta arbetet med att komma med förslag på förbättringar i de EBSCO-system som gruppens medlemmar använder och att utveckla kontakten och samarbetet mellan bibliotek och organisationer kring desamma. För att vara en relevant användargrupp är styrelsen beroende av att me
https://www.ub.lu.se/sites/ub.lu.se/files/verksamhetsplan_2020_for_ebsco_systems_nordic_user_group.pdf - 2026-04-30
Objective. Antileukoproteinase (ALP) is a physiologic inhibitor of granulocytic serine proteases. The present study was undertaken to investigate its therapeutic benefit in an antibody-transfer model of erosive polyarthritis and to elucidate its potential to interfere with immune complex-dependent inflammatory pathways. Methods. Arthritis development was induced in male (BALB/c x B10.Q)F-1 mice by
Background: Nigeria is a major contributor to the global malaria burden. The genetic diversity of malaria parasite populations as well as antibody responses of individuals in affected areas against antigens of the parasite can reveal the transmission intensity, a key information required to control the disease. This work was carried out to determine the allelic frequency of highly polymorphic Plas
Small synthetic ligands for protein purification have become increasingly interesting with the growing need for cheap chromatographic materials for protein purification and especially for the purification of monoclonal antibodies (mAbs). Today, Protein A-based chromatographic resins are the most commonly used capture step in mAb down stream processing; however, the use of Protein A chromatography
Complement C2 deficiency (C2D) is associated with immunological diseases and increased susceptibility to invasive infections caused by encapsulated bacteria such as Neisseria menigitidis. In this study we evaluate the immunogenicity of vaccination against N. menigitidis in C2D. C2D patients (n=22) and controls (n=52) were given a tetravalent meningococcal polysaccharide vaccine. Serum bactericidal
Transplantation of allogeneic embryonic neural tissue is a potential treatment for patients with Parkinson's and Huntington's diseases. The supply of human donor tissue is limited, and alternatives such as the use of animal (e.g., porcine) donor tissue are currently being evaluated. Before porcine grafts can be used clinically, strategies to prevent neural xenograft rejection must be developed. Kn
IgA nephropathy (IgAN) and Henoch-Schönlein purpura (HSP) are diseases characterized by IgA deposits in the kidney and/or skin. Both may arise after upper respiratory tract infections, but the pathogenic mechanisms governing these diseases remain unclear. Patients with IgAN (n = 16) and HSP (n = 17) were included in this study aimed at examining whether IgA-binding M proteins of group A streptococ
It has previously been shown that sera from multiparous women have increased levels of anti-idiotypic antibodies specific for anti-HLA molecules. γ-Globulins prepared from these sera may be superior to commercial preparations of intravenous γ-globulin (IVIg) for inhibiting HLA alloimmunization. To test this, F(ab′)2 fragments prepared from either commercial IVIg or from the sera of men or multipar
Tissue factor pathway inhibitor-2 (TFPI-2) has previously been characterized as an endogenous anticoagulant. TFPI-2 is expressed in the vast majority of cells, mainly secreted into the extracellular matrix. Recently we reported that EDC34, a C-terminal peptide derived from TFPI-2, exerts a broad antimicrobial activity. In the present study, we describe a previously unknown antimicrobial mode of ac
Hu11B6 is a monoclonal antibody that internalizes in cells expressing androgen receptor (AR)-regulated prostate-specific enzyme human kallikrein-related peptidase 2 (hK2; KLK2). In multiple rodent models, Actinium-225-labeled hu11B6-IgG1 ([225Ac]hu11B6-IgG1) has shown promising treatment efficacy. In the present study, we investigated options to enhance and optimize [225Ac]hu11B6 treatment. First,
